Skip to Main Content

Paper Details

Polygenic Risk Scores for Blood Pressure to Assess the Risk of Severe Bevacizumab-Induced Hypertension in Cancer Patients (Alliance).
Clin Pharmacol Ther
1
2022
Bevacizumab, Cancer, Cancer and Leukemia, DBP, Hypertension, PRS, Patients, SNPs, bevacizumab, cancer, essential hypertension, hypertension, patients, single-nucleotide variants
Author NameAffiliation
Nicholas B LarsonMayo Clinic
Braxton D MitchellUniversity of Maryland
  • 1 - 2

Datasets

Release 1.2